Kamal Hamed
Chief Tech/Sci/R&D Officer chez SPERO THERAPEUTICS, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Kamal Hamed is currently the Chief Medical Officer at Spero Therapeutics, Inc. Prior to this, he worked as the Chief Medical Officer at Lysovant Sciences, Inc. Hamed holds a graduate degree from The Johns Hopkins University, an MBA from the University of South Florida, and a doctorate from the American University of Beirut.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SPERO THERAPEUTICS, INC.
1,46% | 02/02/2024 | 788 117 ( 1,46% ) | 1 M $ | 31/03/2024 |
Postes actifs de Kamal Hamed
| Sociétés | Poste | Début |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 15/09/2022 |
Anciens postes connus de Kamal Hamed
| Sociétés | Poste | Fin |
|---|---|---|
| Lysovant Sciences, Inc. | Chief Tech/Sci/R&D Officer | - |
Formation de Kamal Hamed
| The Johns Hopkins University | Graduate Degree |
| University of South Florida | Masters Business Admin |
| American University of Beirut | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SPERO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Lysovant Sciences, Inc. |
